Highlights

  • 333D (ASX:T3D) gained 12.9% as the company’s AI and digital-asset strategy remained in focus.
  • In June, 333D announced an Investment in Firmus alongside an update on AI product development.
  • The company has also been developing digital asset-management tools for healthcare imaging.
  • Earlier 2026 reporting highlighted positive Operating Cash Flow in the March quarter.

333D (ASX:T3D) has gained 12.9% as the company pushes further beyond its legacy digital-content roots into AI-enabled products and strategic technology investments. A June investment in Firmus was paired with an update on internal AI development, while the broader platform increasingly centres on digital asset management in areas such as healthcare imaging. The opportunity is expanding, but commercial traction now needs to catch up with the product narrative.

Firmus Adds an External Technology Exposure

333D announced an investment in Firmus in June. The transaction gives the company exposure to another technology platform while it continues developing its own AI-enabled products.

AI Development Remains an Internal Focus

The June announcement also provided an update on AI product development. 333D has been working on ways to apply digital asset and AI capabilities to commercial workflows.

Healthcare Imaging Creates a Specific Use Case

The company’s platform has focused on digital asset management in healthcare, including DICOM-based imaging. A specialised use case can differentiate the product, although commercial scale remains important.

What to Watch

New customer wins, Revenue from AI-related products, cash flow and any further developments around the Firmus investment are the main indicators.

Risks

333D is a small technology company with early-stage products. Commercial adoption may take time, cash flows can be volatile and strategic investments do not guarantee returns.